PROK
ProKidney Corp.
NASDAQ: PROK · HEALTHCARE · BIOTECHNOLOGY
$1.82
-0.55% today
Updated 2026-04-29
Market cap
$552.59M
P/E ratio
—
P/S ratio
618.80x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
ProKidney Corp. (PROK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-76806.00 | $-25.18M | $-50.30M | $-77.09M | $-90.07M | $-126.35M | $-120.12M |
| Capital expenditures | $1305.00 | $5.46M | $5.19M | $1.85M | $34.20M | $29.51M | $15.20M |
| Depreciation | $867.00 | $964000.00 | $1.98M | $3.04M | $3.85M | $5.43M | — |
| Stock-based comp | $498.00 | $730000.00 | $699000.00 | $74.47M | $30.85M | $29.37M | $25.34M |
| Free cash flow | $-78111.00 | $-30.64M | $-55.49M | $-78.94M | $-124.27M | $-155.86M | $-135.31M |
| Investing cash flow | $-2968.00 | $-5.46M | $-5.19M | $-1.74M | $-329.98M | $20.41M | — |
| Financing cash flow | $20000.00 | $19.99M | $71.47M | $548.52M | $-9.55M | $144.41M | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $469.69M | — | — | — |